medigraphic.com
ISSN 2992-8036 (Electronic)
ISSN 2306-4102 (Print)
Órgano Oficial del Colegio Mexicano de Ortopedia y Traumatología

2017, Number 2

<< Back Next >>

Acta Ortop Mex 2017; 31 (2)

Treatment for Charcot arthropathy. Five-year follow-up

Caldiño-Lozada I, Rojas-Osorio D, Esperón-Hernández R

Language: Spanish
References: 37
Page: 67-74
PDF size: 402.67 Kb.


ABSTRACT

Introduction: Charcot arthropathy is a deformity which alters foot biomechanics and generate bichemical reactions that affect articular joints and bone. The natural history shown us a prevalence on 1% and is classified by Eichenholtz and Simmons modification in four stages; Sanders describe its location in 5 specific areas. Material and methods: Our goal was to evaluate the specific method of treatment depending in the different stages of the deformity according to the literature review and to our proposed algoritm. Results: A succesful treatment were based on alignment, bone healing and independent gait with regular shoes occurred in 85 % of our population. 15% were considered failures because of lack of consolidation, malalignment or use of gait aids and reactivation of the disease. Conclusions: There were no differences in the treatment regardless of the phase of the disease; it is more important the individualized treatment.


REFERENCES

  1. Khanolkar MP, Bain SC, Stephens JW: The diabetic foot. QJM. 2008; 101(9): 685-95.

  2. Vázquez-Gutiérrez M, Mangas-Cruz MA, Cañas García-Otero E, Astorga-Jiménez R: Neuroartropatía diabética en fase aguda: un dilema diagnóstico. A propósito de dos casos y revisión de la bibliografía. Rev Clin Esp. 2005; 205(11): 549-52.

  3. Aguilera-Cros C, Povedano-Gómez J, García-López A: Neuroartropatía de Charcot. Reumatol Clin. 2005; 1(4): 225-7.

  4. Schinca N, Álvarez J: Artropatía neuropática o pie de Charcot. Biomedicina. 2012; 7(1): 44-50.

  5. Mittlmeier T, Klaue K, Haar P, Beck M: Should one consider primary surgical reconstruction in Charcot arthropathy of the feet? Clin Orthop Relat Res. 2010; 468(4): 1002-11.

  6. Wukich DK, Sung W, Wipf SA, Armstrong DG: The consequences of complacency: managing the effects of unrecognized Charcot feet. Diabet Med. 2011; 28(2): 195-8.

  7. Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J: The global burden of diabetic foot disease. Lancet. 2005; 366(9498): 1719-24.

  8. Sommer TC, Lee TH: Charcot foot: the diagnostic dilemma. Am Fam Physician. 2001; 64(9): 1591-8.

  9. Del Castillo-Tirado RA, Fernández-López JA, del Castillo-Tirado FJ: Guía de práctica clínica en el pie diabético. Archivos de Medicina. 2014; 10(2:1): 1-17.

  10. Rogers LC, Frykberg RG, Armstrong DG, Boulton AJ, Edmonds M, Van GH, et al: The Charcot foot in diabetes. Diabetes Care. 2011; 34(9): 2123-9.

  11. Gouveri E, Papanas N: Charcot osteoarthropathy in diabetes: A brief review with an emphasis on clinical practice. World J Diabetes. 2011; 2(5): 59-65.

  12. Sellés DR, Rueda AC, Primo RV, Asencio AF: Pie de Charcot agudo. Casos clínicos. Cirugía General. 2013; 5(2): 17-9.

  13. Secretaría de Salud. Encuesta Nacional de Salud y Nutrición de Medio Camino, 2016. ENSANUT 2016. México: 2016.

  14. Labovitz JM, Shofler DW, Ragothaman KK: The impact of comorbidities on inpatient Charcot neuroarthropathy, cost and utilization. J Diabetes Complications. 2016; 30(4): 710-5.

  15. Wukich DK, Sadoskas D, Vaudreuil NJ, Fourman M: Comparison of diabetic Charcot patients with and without foot wounds. Foot Ankle Int. 2017; 38(2): 140-8.

  16. Miller RJ: Neuropathic minimally invasive surgeries (NEMESIS): percutaneous diabetic foot surgery and reconstruction. Foot Ankle Clin. 2016; 21(3): 595-627.

  17. Bariteau JT, Tenenbaum S, Rabinovich A, Brodsky JW: Charcot arthropathy of the foot and ankle in patients with idiopathic neuropathy. Foot Ankle Int. 2014; 35(10): 996-1001.

  18. Milera-Rodríguez J, Solís-Cartas U, Gil-Armenteros R, Guanche-Hernández M: Artropatía de Charcot y osteomielitis en un paciente diabético. Rev Cuba Reumatol. 2014; 16(2): 235-9.

  19. Holmes C, Schmidt B, Munson M, Wrobel JS: Charcot stage 0: A review and considerations for making the correct diagnosis early. Clinical Diabetes and Endocrinology. 2015; 1: 18.

  20. Lowery NJ, Woods JB, Armstrong DG, Wukich DK: Surgical management of Charcot neuroarthropathy of the foot and ankle: a systematic review. Foot Ankle Int. 2012; 33(2): 113-21.

  21. Lozano-Platonoff A, Mejía-Mendoza MDF, Ibáñez-Doria M, Contreras-Ruiz J: Estándar de oro en el manejo del pie diabético: yeso de contacto total. Gaceta Médica de México. 2014; 150(1): 58-64.

  22. Pinzur MS, Lio T, Posner M: Treatment of Eichenholtz stage I Charcot foot arthropathy with a weight-bearing total contact cast. Foot Ankle Int. 2006; 27(5): 324-9.

  23. Panagakos P, Ullom N, Boc SF: Salvage arthrodesis for Charcot arthropathy. Clin Podiatr Med Surg. 2012; 29(1): 115-35.

  24. Pinzur M: Surgical versus accommodative treatment for Charcot arthropathy of the midfoot. Foot Ankle Int. 2004; 25(8): 545-9.

  25. Simon SR, Tejwani SG, Wilson DL, Santner TJ, Denniston NL: Arthrodesis as an early alternative to nonoperative management of Charcot arthropathy of the diabetic foot. J Bone Joint Surg Am. 2000; 82-A(7): 939-50.

  26. Baravarian B, Van Gils CC: Arthrodesis of the Charcot foot and ankle. Clin Podiatr Med Surg. 2004; 21(2): 271-89.

  27. Richman J, Cota A, Weinfeld S: Intramedullary nailing and external ring fixation for tibiotalocalcaneal arthrodesis in Charcot arthropathy. Foot Ankle Int. 2017; 38(2): 149-52.

  28. Butt DA, Hester T, Bilal A, Edmonds M, Kavarthapu V: The medial column Synthes Midfoot Fusion Bolt is associated with unacceptable rates of failure in corrective fusion for Charcot deformity: Results from a consecutive case series. Bone Joint J. 2015; 97-B(6): 809-13.

  29. Lamm BM, Gottlieb HD, Paley D: A two-stage percutaneous approach to Charcot diabetic foot reconstruction. J Foot Ankle Surg. 2010; 49(6): 517-22.

  30. Carranza-Becano A, Fernández-Torres JJ: Cirugía por mínima incisión en el tratamiento del pie neuropático. Rev del Pie y Tobillo. 2007; 21: 101-6.

  31. Hingsammer AM, Bauer D, Renner N, Borbas P, Boeni T, Berli M: Correlation of systemic inflammatory markers with radiographic stages of Charcot osteoarthropathy. Foot Ankle Int. 2016; 37(9): 924-8.

  32. Osterhoff G, Böni T, Berli M: Recurrence of acute Charcot neuropathic osteoarthropathy after conservative treatment. Foot Ankle Int. 2013; 34(3): 359-64.

  33. Van der Ven A, Chapman CB, Bowker JH: Charcot neuroarthropathy of the foot and ankle. J Am Acad Orthop Surg. 2009; 17(9): 562-71.

  34. Koller A, Meissner SA, Podella M, Fiedler R: Orthotic management of Charcot feet after external fixation surgery. Clin Podiatr Med Surg. 2007; 24(3): 583-99, xi.

  35. Richard JL, Almasri M, Schuldiner S: Treatment of acute Charcot foot with bisphosphonates: a systematic review of the literature. Diabetologia. 2012; 55(5): 1258-64.

  36. Concepción-Medina T, Rodríguez-Hernández O, Illada-Navarro L: Artropatía de Charcot. Importancia del diagnóstico en fase aguda. Rehabilitación (Madr). 2011; 45(1): 75-7.

  37. Dhawan V, Spratt KF, Pinzur MS, Baumhauer J, Rudicel S, Saltzman CL: Reliability of AOFAS diabetic foot questionnaire in Charcot arthropathy: stability, internal consistency, and measurable difference. Foot Ankle Int. 2005; 26(9): 717-31.




2020     |     www.medigraphic.com